10-K Decoder · All companies

Harmony Biosciences Holdings, Inc.

HRMY · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$868M$715M+21.5%
Operating income$208M$191M+9.2%
Net income$159M$145M+9.1%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$269M$240M+12.3%
Operating income$54.2M$65.5M−17.3%
Net income$48.2M$50.9M−5.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Harmony Biosciences's revenue in FY2025?
$868M in FY2025 (Fiscal year ended Dec 31, 2025), +21.5% vs $715M a year earlier, per its 10-K filed Feb 2026.
Was Harmony Biosciences profitable in FY2025?
Yes: net income was $159M and operating income $208M in FY2025.
What was Harmony Biosciences's revenue in Q3 2026?
$269M (+12.3% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.